Upcoming Webinars
- Beyond Safety and Efficacy: Environmental Risk Assessment under 2024 revised EMA Guideline
22 April 2026 | 11am CEST, 2:30 IST (India)
Learn more & register
On Demand Webinars
Regulatory Support
- Réduire l’impact environnemental des produits pharmaceutiques : enjeux et cadre réglementaire ***Presented in French - Recorded February 24, 2026
- US and Canadian Regulatory Landscape for Rare Disease Drug Development - Recorded July 13, 2021
- Prérequis pour déterminer les valeurs limites d’exposition de principes actifs pharmaceutiques ***Presented in French - Recorded June 19, 2018
- Comparison of Health Claim Frameworks Between the U.S., EU, and Other Jurisdictions - Recorded Nov 23, 2015
Toxicology Support
- Navigating Challenges in VOC Testing and Toxicology: Ensuring Compliance and Safety - Recorded July 31, 2025
- Screening of Impurities for Mutagenic Potential: How to Perform an ICH M7-Compliant Assessment - Recorded October 26, 2023
- Méthodes in silico pour l'évaluation toxicologique - Recorded June 6, 2023
- In Silico Methods for Toxicological Assessment - Recorded May 24, 2023
- Safety Assessment of Pharmaceuticals Impurities (ICH Q3A, ICH Q3B and ICH M7) - Recorded May 16, 2023
- Évaluation de la sécurité des impuretés pharmaceutiques (ICH Q3A, ICH Q3B et ICH M7) - Recorded April 15, 2023
- Determination of Health Based Exposure Limit of chemicals substances: Permitted Daily Exposure and Occupational Exposure Limit - Recorded June 23, 2022
- Drug Product Impurities: Analytical and Toxicological Considerations - Recorded November 5, 2020
- Best Practices For E&L Studies: From Chemical Analysis to Tox Assessment - Recorded October 29, 2020